HealthBio
HealthBioAI is a commercial-stage biotech company focused on diagnosing and treating chronic inflammatory diseases, starting with Long Covid. The company uses machine learning and AI-based precision diagnostics to identify the molecular root causes of immune-mediated diseases. Their patented platform includes diagnostic testing (IncellKINE™), a combination pharmaceutical treatment, and biometric remote monitoring devices. HealthBioAI has FDA acceptance for a randomized clinical trial for Long Covid treatment using a combination of maraviroc and pravastatin. The company aims to provide a comprehensive patient journey from diagnosis to treatment and management, targeting millions of patients with chronic inflammatory diseases such as Long Covid, chronic Lyme, fibromyalgia, and ME/CFS. Their approach leverages AI-driven diagnostics, predictive pathology, and drug discovery to innovate in immune dysregulation and vascular inflammation.
HealthBio
HealthBioAI is a commercial-stage biotech company focused on diagnosing and treating chronic inflammatory diseases, starting with Long Covid. The company uses machine learning and AI-based precision diagnostics to identify the molecular root causes of immune-mediated diseases. Their patented platform includes diagnostic testing (IncellKINE™), a combination pharmaceutical treatment, and biometric remote monitoring devices. HealthBioAI has FDA acceptance for a randomized clinical trial for Long Covid treatment using a combination of maraviroc and pravastatin. The company aims to provide a comprehensive patient journey from diagnosis to treatment and management, targeting millions of patients with chronic inflammatory diseases such as Long Covid, chronic Lyme, fibromyalgia, and ME/CFS. Their approach leverages AI-driven diagnostics, predictive pathology, and drug discovery to innovate in immune dysregulation and vascular inflammation.